Table 1.
Comparison of major clinico-pathological factors between NSCLC patients with or without bone metastasis
| Characteristics | Bone metastasis (n = 45) |
Non-bone metastasis (n = 60) |
P value |
|---|---|---|---|
| n (%) | n (%) | ||
| Gender | |||
| Male |
28 (62.2) |
37 (61.7) |
0.954 |
| Female |
17 (37.8) |
23 (38.3) |
|
| Age (mean ± SD) (yr.) |
55.8 ± 12.1 |
57.4 ± 7.2 |
0.398 |
| Histopathology | |||
| Adenocarcinoma |
39 (86.7) |
50 (83.5) |
0.567 |
| Non-adenocarcinoma |
6 (13.3) |
10 (16.7) |
|
| Stage | |||
| IIIa |
33 (73.3) |
53 (86.7) |
0.048 |
| IIIb |
12 (26.7) |
7 (13.3) |
|
| Adjuvant chemotherapy | |||
| Yes |
30 (66.7) |
46 (76.7) |
0.828 |
| No | 15 (33.3) | 14 (23.3) | |